Podcasts about Psoriasis

2026 EULAR Preview Imaging in Subclinical Psoriatic Arthritis Dietary Interventions in PsA This Is a Woman's World: Women's Health in Rheumatic Disease Impact of Synovial Biopsy-Driven Therapeutic Stratification in PsA Can We Stop PsA Before it Starts? BE BOLD: Going Where No PsA Trial Has Gone Before BMI Outranks Treatment in PsA Outcomes? Debate: Combination Therapies for Inflammatory Arthritis? Combination Biologics in PsA: MRI Findings from AFFINITY Combination Therapy in SpA The Case for Dual Pathway Blockade in Refractory PsA The AFFINITY Study: Combination Treatment in PsA PsA Potpourri: Probiotics & Head-to-Head Data Transition from Psoriasis to Psoriatic Arthritis MACE and Safety Profile of bDMARDs/JAKis in axSpA and PsA Guselkumab Delivers Across the PsA Disease Spectrum: APEX Trial  

Debate: Combination Therapies for Inflammatory Arthritis? Combination Biologics in PsA: MRI Findings from AFFINITY Combination Therapy in SpA Digital Patient Education in RA The Case for Dual Pathway Blockade in Refractory PsA The AFFINITY Study: Combination Treatment in PsA PsA Potpourri: Probiotics & Head-to-Head Data Transition from Psoriasis to Psoriatic Arthritis  

Description:  How do GLP-1 receptor agonists or GIP agonists work and what is the impact for my psoriatic disease? Hear dermatologist Dr. Ronald Prussick and cardio-immunologist Dr. Brittany Weber answer such questions and more.           Join host Archie Franklin as he takes a deep dive into the use of GLP-1 receptor agonists and GIP agonists and the convergence of systemic inflammation related to psoriatic disease with renowned dermatologist and Vice Chair of the NPF Medical Board, Dr. Ronald Prussick from Washington Dermatology Center in Rockville and Frederick, MD, and, cardio-immunologist Dr. Brittany Weber, Director of the Cardio-Rheumatology/ Cardio-Dermatology Program at the University of Texas Southwestern. Learn more about the use of incretin hormones, the impact of weight management on psoriatic disease, metabolic and cardiovascular risk, as well as results from the TOGETHER-Pso and TOGETHER-PsA clinical trials.  This episode addresses the actions of incretin hormones (GLP-1 receptor agonist and GIP agonist) and how such use may be beneficial in the management of inflammation related to psoriasis and psoriatic arthritis.  Thank you to Lilly for their support of this program activity.  Timestamps: (0:00)  Intro to Psoriasis Uncovered & guest welcome dermatologist Dr. Ronald Prussick and cardio-immunologist Dr. Brittany Weber.  (1:35)  What are incretin hormones and how GLP-1 or GIP receptor agonists (RA) inhibit appetite to initiate weight loss. (3:29)  Why GLP-1 RAs are of interest in the management of psoriasis and psoriatic arthritis. (5:23)  The metabolic, cardiovascular, and psoriatic disease convergence. (7:19)  Will reduction of inflammation impact cardiovascular risk? (10:59) Treatment challenges associated with having psoriatic disease and being overweight or obese. (13:45)  Key points around the use of GLP-1 receptor agonists when managing psoriasis and psoriatic arthritis. (17:06)  Results of the TOGETHER-PsO and TOGETHER-PsA phase 3 clinical trials combining use of an IL-17 inhibitor and a GIP and GLP-1                receptor agonist therapy. (19:07)  Having the conversation of adding a GLP-1 RA medication to a treatment regimen. (22:40)  The paradigm shift of GLP-1 receptor agonists and the impact they can have on shared inflammatory pathways. Key Takeaways: ·       Glucagon-like peptide-1 (GLP-1) receptor agonists and glucose-dependent insulinotropic polypeptide (GIP) agonists are two incretin hormones that assist in managing excess body weight -- which as a result can be helpful in managing inflammation in the body.   ·       Psoriasis isn't just a skin and joint disease. It's a complex network of systemic inflammation with shared inflammatory pathways that worsens with increased weight impacting the severity of the disease, and accelerates the risk of metabolic dysfunction, and cardiovascular disease.   ·       The best outcomes occur as a result of multidisciplinary collaboration to address the impact of excess weight and systemic inflammation. If you are struggling to lose weight with diet and exercise, speak with your medical team about your options including the use of GLP-1 or GIP agonists.   Guest Bios: Renowned dermatologist Ronald Prussick, M.D., Medical Director of the Washington Dermatology Center in Rockville and Fredrick, Maryland, specializes in the treatment of psoriasis along with other diseases of the skin, hair, and nails. Dr. Prussick is also a Clinical Associate Professor in Dermatology at George Washington University in Washington, D.C.. Dr. Prussick has a research interest in the impact of diet on psoriatic disease and metabolic health, first becoming interested after being involved in Dr. Joel Gelfand and Dr. Nehal Mehta's work in vascular inflammation trials using FDG-PET/CT scans to view systemic and cardiovascular inflammation associated with psoriatic disease. Dr. Prussick has since participated in the development of the 2018 Dietary Recommendations for Adults with Psoriasis or Psoriatic Arthritis and more recently the position statement "GLP-1 Receptor Agonists in Psoriasis: A Primer from the National Psoriasis Foundation Medical Board". Dr. Prussick is Vice Chair of the NPF Medical Board which provides clinical direction, treatment guidance, and education oversight to the organization and its Executive leaders.  Brittany Weber, M.D., Ph.D. is a cardio-immunologist who is the Director of the Cardio-Rheumatology/ Cardio-Dermatology Program at the University of Texas Southwestern. She is also a member of the Division of Cardiology, a clinical investigator, and imaging specialist. Dr. Weber's research integrates advanced imaging, molecular biology, clinical trials, and population health to understand how systemic inflammation and immune deregulation drives cardiovascular dysfunction. Prior to joining UT Southwestern in 2025, Dr. Weber served on the faculty at Harvard Medical School and was the Director of the Cardio-Rheumatology Clinic at Brigham and Women's Hospital, a nationally recognized clinic addressing inflammation-related heart disease through collaborative, patient centered care. Dr. Weber is also an author on the position statement "GLP-1 Receptor Agonists in Psoriasis: A Primer from the National Psoriasis Foundation Medical Board". Resources: "The Metabolic Collison and How You Can Take Control with Psoriatic Disease" podcast episode with dermatologist Dr. Ronald Prussick and registered dietitian Danielle Cahalan   "NPF Medical Board Issues GLP-1 Primer for Dermatologists" Press Release "Finding My Path to Managing Psoriatic Disease and Excess Weight" podcast episode featuring dermatologist Dr. Erin Boh, patient advocate Brian Lehrschal, and moderator Jennifer Bomberger. 

Michele Scarlet sits down with RN, Nurse Practitioner, and Functional Diagnostic Nutrition Practitioner Connie Wade for an honest conversation about what 25 years inside the emergency room taught her about the limits of conventional medicine, why her own doctor told her she was not "sick enough" to treat, and how she finally healed the symptoms she had been "swiping away" for years. In this powerful Health Detective Podcast episode, Connie shares her personal journey through psoriasis, debilitating joint pain at 48, chronic reflux, daily ibuprofen use, estrogen dominance, heavy painful periods, more than 20 years of night shift, H. pylori, an overwhelmed liver and gallbladder, food sensitivities to her favorite foods, and a depleted gut microbiome. Together, Michele and Connie unpack how functional lab testing gave Connie the vindication she had been looking for, why she healed in three months once she addressed the root causes, and why she chose to keep working in the ER while building her functional health practice on the side. This episode dives deep into: Why her doctor said "she wasn't sick enough" and sent her home with ibuprofen The functional labs that finally explained her symptoms after years of being dismissed How 20 plus years of night shift flatlined her cortisol and disrupted her hormones H. pylori, food sensitivities, and the gut findings that changed everything Why psoriasis, joint pain, and heavy periods are not just "normal aging" The reframe that helped Connie cut gluten, sugar, and dairy without feeling deprived Why so many nurses are leaving bedside nursing and the third option most do not consider How to build a functional nursing side practice without leaving your license or your job Why going all in or all out of conventional medicine limits your reach as a clinician The four simple daily practices Connie recommends to every patient How to ask your family for support when you start your healing journey Michele and Connie also discuss why the body is constantly trying to send messages, why most of us swipe them away for years, and why functional lab testing catches dysfunction long before conventional labs ever turn "abnormal." If you are a woman struggling with joint pain, psoriasis, hormone imbalance, or symptoms your doctor keeps dismissing, or you are a nurse, NP, or clinician quietly exploring functional medicine as a career path, this episode will change how you view your body and what is possible.

This podcast episode features a powerful role reversal as host Sarah Dawkins, author of Heal Yourself and a registered nurse, steps into the interviewee seat. Guest host Bethany Shipley explores Sarah's journey from the front lines of cardiothoracic nursing to becoming a global advocate for natural self-healing.Episode OverviewSarah spent years on the front lines of surgery, surrounded by the best medicine money could buy. But while she was saving lives, her own body was falling apart. Psoriasis, depression, PTSD and chronic pain.Sarah didn't just find a new prescription, she found a new path. Meet Sarah Dawkins: The nurse who stopped following orders, defied her training and healed herself. We're diving into the "crisis of conscience" that changed everything.Why Listen?If you have ever felt "sick and tired of being sick and tired," this episode offers a roadmap of hope. Sarah's story proves that healing isn't just for a "special" few, it is a possibility for anyone willing to listen to their body and step outside their comfort zone.Key Topics & Timestamps02:10 The specific 2005 encounter in a Florida hospital that challenged Sarah's beliefs about pharmaceuticals.02:54 Navigating a deep depression and the "crisis of conscience" while working in cardiothoracic surgery.03:53 Why Sarah hid her book for 5 years and how she eventually gathered 74 contributors to provide "social proof" that healing happens.07:01 The moment Sarah was reported to the nursing board for sharing her natural thyroid healing journey.09:42 A list of the physical conditions Sarah healed, from psoriasis and acid reflux to chronic joint pain and PTSD.12:06 An honest look at bulimia, emotional eating, and how "disgust" became a catalyst for change.18:05 Sarah's simple rule: "If I don't buy it, I can't eat it."20:34 The "Single-Ingredient Food" strategy for feeding picky kids and busy families.24:29 Why Sarah chose to bypass traditional publishing to get the message to the public faster.28:02 Understanding the metaphysical link between "frozen shoulders" and carrying the weight of the world.29:51 How spinal pain often correlates to feelings of financial or personal insecurity.31:41 Using short meditations to stop "checking out" via food, alcohol, or scrolling.33:45 Why we are afraid to trust our own feelings and how to stop seeking external approval.Bethany's Bio Bethany Shipley is a writer, speaker, and philosophical guide for people who are ready to live a life that is true to them.Her work centers around a powerful idea: Being influences Doing. When you understand who you are at your core and have the courage to live from that place, your actions naturally align and your life begins to reflect something deeply authentic.Bethany is known for blending grounded insight with spiritual depth, helping people reconnect to their instinct, expression, and internal compass. She moves beyond hype and surface-level encouragement, guiding people into a lived experience of alignment.Through her podcast, Market Your Personal Brand and upcoming book, she empowers and inspires people to live an authentic life.Connect with Bethany https://www.bethanyshipley.com/Who am I?Sarah Dawkins is a passionate Holistic Health and Healing Coach, international speaker and author of Heal Yourself. She's also a multi-award-winning entrepreneur and the award-winning host of the uplifting podcast Mind Body Medicine for Self Healers with Sarah Dawkins.With over 20 years' experience as a Registered Nurse, Sarah combines her deep understanding of conventional medicine with her own powerful self-healing journey to create a truly integrative approach. Having overcome multiple chronic health challenges herself, she now supports others in uncovering and addressing the root causes of their symptoms, helping them restore balance, reclaim their energy and create lasting, vibrant wellness.www.sarahdawkins.com

Dr. Marty Makary out as FDA Commissioner—was he the victim of a BigPharma purge? Are “liquid biopsies” useful for predicting recurrences, as well as guiding therapy, for cancer? Nighttime smartphone by adolescents surges, eroding kids' sleep needs; Persistent itch may require an “all of the above” approach to break its vicious cycle—could topical vitamin B12 provide an answer? Study critiques research methods that fast-tracked new Alzheimer's drugs.

If you're struggling with dyshidrotic eczema and stuck in the cycle of restrictive diets, expensive creams, and an endless search for answers, this episode offers a fresh perspective. Discover why hand eczema is connected to deeper issues like gut health imbalances, nutrient deficiencies, and immune system dysfunction, rather than just blaming it all on food sensitivities.In this conversation, I explore how common approaches to hand eczema can actually make your rash worse, along with practical insights into what steps support healing. If you've had enough of cracked, itchy, painful, or constantly flaring hands, this episode is for you!⭐️Mentioned in This Episode:- See all the references

Welcome back to the Homeopathy247 podcast! In Episode 202, Mary is joined by Dr. Nitin Deshmukh, a highly experienced homeopath from India, to explore a condition that affects millions worldwide: psoriasis. If you or a loved one have been struggling with stubborn skin flares, this episode sheds light on how to address the true root cause. Understanding Psoriasis Beyond the Skin Dr. Deshmukh explains that clinically, psoriasis is an autoimmune condition where the skin's maturation process is hyper-accelerated. Instead of taking weeks, skin cells mature rapidly, creating red, inflamed scales and flakes. However, the physical symptoms are only half the story. According to Dr. Deshmukh, psoriasis is an external manifestation of an internally deranged system. The most common triggers? Emotional stress, mental trauma, and family conflicts. He beautifully describes psoriasis as an "erupting volcano." When deep emotions like guilt, suppression, or feelings of being devalued cannot be safely expressed, the immune system weakens, and the body pushes these feelings out through the skin. Mainstream Medicine vs. The Homeopathic Approach Mainstream medicine excels at soothing the skin's surface during severe flare-ups using anti-inflammatories and anti-allergics. However, these treatments often only manage the symptoms temporarily. Homeopathy for psoriasis works differently. Following Hering's Law of Cure, homeopathy treats the patient from the inside out. By sitting down and acting as an emotional detective, a homeopath identifies the specific emotional conflict that triggered the immune suppression. A Remarkable Case Study To illustrate this inside-out healing, Dr. Deshmukh shares a fascinating case of a 32-year-old man suffering from erythrodermic psoriasis—one of the most severe forms of the condition. The patient's flare-ups began shortly after his marriage. Severe conflicts between his new wife and his sister-in-law forced him to move out of his beloved joint family home. Feeling disgraced, outcast, and deeply homesick, his emotional turmoil erupted on his skin. By matching these exact emotional symptoms, Dr. Deshmukh prescribed a single dose of the constitutional remedy Sulphur 30. Within 45 days, the flaking was vastly reduced, and within six months, his skin was clear—with no recurrence in over three years! The Main Takeaway Healing chronic conditions takes patience, but you do not have to suffer forever. By finding the exact core of your emotional and physical symptoms, a constitutional homeopathic remedy can help your immune system naturally restore its balance. Important links mentioned in this episode: Visit Dr. Nitin's website: https://www.herambhomeopathy.com/ Know more about Dr. Nitin: https://homeopathy247.com/professional-homeopaths-team/nitin-deshmukh/   You can also subscribe to our podcast channels available on your favourite podcast listening app below: Apple Podcast: https://podcasts.apple.com/us/podcast/homeopathy247-podcast/id1628767810 Spotify: https://open.spotify.com/show/39rjXAReQ33hGceW1E50dk Follow us on our social media accounts: Facebook: https://www.facebook.com/homeopathy247 Instagram: https://www.instagram.com/homeopathy247 You can also visit our website at https://homeopathy247.com/

In this episode of Wholistic Living, we dive into the powerful connection between myrosinase, gut health, eczema, inflammation, detoxification, and the microbiome. Learn why cruciferous vegetables like broccoli, kale, arugula, cabbage, and broccoli sprouts may not provide their full benefits if the enzyme myrosinase is lacking or destroyed through cooking and poor gut health. We explore how low myrosinase activity on stool testing may reflect dysbiosis, poor microbial diversity, chronic inflammation, mold exposure, antibiotic damage, sluggish bile flow, and impaired detoxification pathways. Discover how this impacts sulforaphane production, NRF2 activation, glutathione, histamine intolerance, hormone balance, liver detoxification, autoimmune conditions, eczema, psoriasis, and skin inflammation. You'll also learn practical ways to naturally increase sulforaphane activation, preserve myrosinase in foods, support gut bacteria involved in glucosinolate metabolism, and improve detoxification through nutrition and lifestyle.Topics covered:What myrosinase is and why it mattersLow myrosinase on stool tests explainedSulforaphane, NRF2, and glutathioneEczema, psoriasis, and chronic inflammationGut dysbiosis and detoxificationMold illness and histamine intoleranceHow cooking affects broccoli and cruciferous vegetablesBroccoli sprouts, mustard seed powder, and sulfur-rich foodsHormone balance, estrogen detox, and liver healthIf you struggle with eczema, skin issues, autoimmune symptoms, histamine reactions, poor detoxification, gut problems, or chronic inflammation, this episode is packed with science-backed holistic insights you do not want to miss.Equip Grass fed protein: www.equipfoods.com/MARLAWork with me: https://holisticspring.com/contactInstagram: www.instagram.com/wholistichomeopath

Description: "When joint pain is present, the diagnosis of psoriatic arthritis needs to be made as soon as possible, ideally within six months to limit joint inflammation" Dr. Vinod Chandran mentions as he discusses efforts to identify a diagnostic test for those at risk of developing psoriatic arthritis.          Join host Jeff Brown as he speaks with leading rheumatologist and clinician scientist Dr. Vinod Chandran, Director of the Gladman Krembil Psoriatic Arthritis Program, Schroeder Arthritis Institute, University Health Network and the Departments of Medicine, Laboratory Medicine and Pathobiology, and the Institute of Medical Science at the University of Toronto to learn more about the progress and promising results towards developing a psoriatic arthritis diagnostic test through multi-omic assays and identifying the distinct differences between psoriasis and psoriatic arthritis.  This episode provides an update on the progress to date of the NPF PsA Diagnostic Test grant initiative which has shown promising results with a potential test entering prospective study in multiple sites soon.   Thank you to Johnson and Johnson for their support of this program activity. Timestamps: (0:00)          Intro to Psoriasis Uncovered & guest welcome rheumatologist Dr. Vinod Chandran.    (0:52)          It is challenging to diagnose psoriatic arthritis with many factors leading to a delay in diagnosis. (4:56)          The start of Dr. Chandran's involvement with the PsA Diagnostic Test Grant project.   (7:55)          The different types of omics and the definition of multi-omic. (9:57)          How the multi-omic approach is used to find biomarkers relative to a specific disease pattern. (11:08)        Development of a predictive or prevention-based test using gene expression.      (13:46)        First year results identify 200 markers across different omic approaches that distinguish psoriatic arthritis from psoriasis.    (14:58)        The significance of MRNA vs mIcroRNA's use in development of a diagnostic test and how critical that is to dissemination of a                     potential test. (17:08)        Identifying the skin-joint axis in relation to different types of arthritis. (20:20)        Next steps to moving the diagnostic test research forward as a prospective study in multiple sites and the cost effectiveness of                  delivering the test.   (23:13)        If you have psoriasis, musculoskeletal, back, and joint pain think of psoriatic arthritis and be diagnosed early to maintain a good                 quality of life. Key Takeaways: ·       Given challenges associated with diagnosing psoriatic arthritis and the impact on quality of life, in 2019 NPF launched the PsA Diagnostic Test Grant project with the goal of developing an early stage test that would identify and diagnose those with psoriatic arthritis before debilitating  joint damage begins.   ·       Progress towards a PsA Diagnostic Test includes the study of multi-omic data sets where 200 distinct biomarkers have been identified leading to a greater understanding of the different pathways between psoriatic arthritis, psoriasis, and the skin joint axis.  ·       A potential diagnostic test is now moving towards the prospective study phase. Until the test is available and if joint pain is present and you have psoriasis, ask your health care provider if it could be psoriatic arthritis and treat appropriately.  Guest Bio: Vinod Chandran, MBBS, MD, DM, PhD is a rheumatologist, clinician scientist, and Director of the Gladman Krembil Psoriatic Arthritis Program, Schroeder Arthritis Institute, University Health Network and the Departments of Medicine, Laboratory Medicine and Pathobiology, and the Institute of Medical Science at the University of Toronto where he is also a Professor of Medicine. His specialties include internal medicine, immunology, rheumatology, and genetic epidemiology. His research focus is on the development of biomarker-based strategies to improve early diagnosis and prognosis of psoriasis and psoriatic arthritis, identification of new treatment targets especially for those who do not respond to current therapies, and strategies to reduce the impact of disease. Dr. Chandran is a Co-Vice President of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis or GRAPPA. He is an active collaborator in a multi-center research consortia such as the International Psoriasis and Arthritis Research Team and the Spondyloarthritis Research Consortium of Canada. Dr. Chandran is the recipient of research funding from the National Psoriasis Foundation for his work in identifying a "Multi-omic Diagnostic Test for PsA in Psoriasis Patients". Resources: "Understanding the NPF Psoriatic Arthritis Diagnostic Test Grant Outcomes" Advance Online. February 18, 2026.  "Managing Chronic Pain with Psoriatic Arthritis" Psoriasis Uncovered podcast episode with physiatrist Dr. Erin Maslowski, LB Herbert who lives with psoriatic disease, and moderator Susan McClelland-Tobert, a retired pediatric cardiologist who also lives with psoriatic disease. Glossary of terms: mRNA: Messenger RNA carries protein information or instructions from the DNA in a cell's nucleus to the cell's interior where the sequence is read and translated into corresponding amino acids for growing protein chains. Micro-RNA (miRNA):  Micro-RNA act as the regulator. They are short and bind to specific target mRNA's to degrade or inhibit production of protein. 

Skin has always told stories. For thousands of years, those whose skin behaved differently — scaling, thickening, inflaming — were feared, isolated, and misunderstood. Psoriasis was long lumped together with leprosy, its sufferers cast out rather than cared for. It would take centuries before medicine began to separate these conditions, and longer still before we understood what was really happening beneath the surface. Psoriasis is not an infection, not a curse, not a failure of hygiene. It is the immune system turning on itself, a complex, chronic inflammatory disease that affects not just skin but joints, confidence, and quality of life. It touches roughly 2-3% of the population, and for many it is a lifelong companion. Today we have a clinical dermatologist and a dermatopathologist to help us understand what psoriasis looks like to the clinician, what it reveals under the microscope, and how our understanding of its immunological roots has transformed the way we treat it. This is the story of psoriasis. Our Special Guests: Associate Professor Laura Scardamaglia, a Consultant Dermatologist, a Fellow of the Australasian College of Dermatology, and Clinical Associate Professor at the University of Melbourne. Dr Grace Liu is an Anatomical Pathologist with Histopath in Sydney, Australia. Listen: This Medical Life podcast is available on all podcasting services and Spotify. Help support us on our donation page.See omnystudio.com/listener for privacy information.

What comes first: the obesity or the skin inflammation?  We've got just the expert to help us find out. This week, we're joined by Dr. Ganary Dabiri as she walks us through the relationship of obesity and the skin. Listen in as she discusses skin diseases, how to use "people first" language, and the clinical possibilities of GLP-1 medications. Each Thursday, join Dr. Raja and Dr. Hadar, board-certified dermatologists, as they share the latest evidence-based research in integrative dermatology. For access to CE/CME courses, become a member at LearnSkin.com. Dr. Ganary Dabiri is double board-certified in Dermatology and in Obesity Medicine. She earned her graduate and medical degree from Albany Medical College. She completed her Dermatology Residency at Roger Williams Medical Center. In 2024 she completed her requirements and obtained board certification in Obesity Medicine. Dr. Dabiri is an adjunct assistant professor at Albany Medical College. She works in private practice in Milford, Massachusetts. In 2024, Dr. Dabiri started the first Skin Inflammation and Obesity Medicine Specialty Clinic in Massachusetts. This comprehensive clinic focuses on and treats patients not only for their chronic inflammatory dermatologic condition such as Psoriasis, Hidradenitis Suppurativa, PCOS, and Atopic Dermatitis but treats their concurrent obesity. Since the inception of this clinic, she has helped numerous patients achieve clearer skin, improve their joint health, but equally if not more importantly - improve their overall health.

Could GLP-1 medications be the missing piece in treating inflammatory skin disease? In this episode of Science is Skin, Dr. Ted Lain sits down with Dr. Lindsey Bordone — former Columbia University associate professor of dermatology, now in private practice at Bordone Dermatology in Scottsdale, Arizona — for a deep dive into metabolic disease and the skin. Dr. Bordone was among the first dermatologists to prescribe GLP-1 agonists for her patients, and in this conversation she explains exactly why. From the link between hyperinsulinemia and chronic inflammation to the visible skin signs of insulin resistance — skin tags, acanthosis nigricans, forearm hair loss — she makes the case that dermatologists are uniquely positioned to catch metabolic disease before any other specialty. Dr. Bordone walks through how she uses tirzepatide (Mounjaro/Zepbound), semaglutide (Ozempic/Wegovy), and the emerging triple-G drug retatrutide, including her lab protocols, dosing philosophy, how to manage GI side effects, and the surprising interaction between GLP-1s and estrogen therapy. In this episode: Why high BMI reduces biologic efficacy in psoriasis patients How to check fasting insulin (HOMA-IR) and why most physicians aren't doing it Skin signs of insulin resistance: skin tags, forearm hair loss, and neck skin thickening Tirzepatide vs. semaglutide vs. retatrutide — how to choose and when Retatrutide's remarkable 93% fatty liver clearance rate in clinical trials The truth about sarcopenia and muscle loss on GLP-1 medications Dosing protocols, side effect management, and when NOT to escalate quickly Protein intake recommendations during active weight loss Estrogen and GLP-1 synergy — what dermatologists need to know Lab work to run before and during GLP-1 therapy How to build an insurance case for continued medication coverage Resources mentioned: HOMA-IR fasting insulin/glucose testing AAD resources on metabolic dermatology Bordone Dermatology — Scottsdale, Arizona Enjoyed this episode? Share it with a colleague and leave us a five-star review. Subscribe so you never miss an episode of Science is Skin. To watch this and other episodes, be sure to check out our YouTube page DISCLAIMER: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.See omnystudio.com/listener for privacy information.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/WNB865. CME/AAPA credit will be available until April 21, 2027.A New Era in Psoriasis Care With Oral IL-23 Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Johnson & Johnson.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/WNB865. CME/AAPA credit will be available until April 21, 2027.A New Era in Psoriasis Care With Oral IL-23 Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Johnson & Johnson.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/WNB865. CME/AAPA credit will be available until April 21, 2027.A New Era in Psoriasis Care With Oral IL-23 Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Johnson & Johnson.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/WNB865. CME/AAPA credit will be available until April 21, 2027.A New Era in Psoriasis Care With Oral IL-23 Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Johnson & Johnson.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/WNB865. CME/AAPA credit will be available until April 21, 2027.A New Era in Psoriasis Care With Oral IL-23 Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Johnson & Johnson.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/WNB865. CME/AAPA credit will be available until April 21, 2027.A New Era in Psoriasis Care With Oral IL-23 Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Johnson & Johnson.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/WNB865. CME/AAPA credit will be available until April 21, 2027.A New Era in Psoriasis Care With Oral IL-23 Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Johnson & Johnson.Disclosure information is available at the beginning of the video presentation.

Subscribe to our YouTube channel and be updated with our latest episodes. Welcome to the 200th episode of the Homeopathy247 podcast! Host Mary Greensmith takes us on a journey through some of the most impactful and inspiring clips from past episodes. Featuring expert homeopaths Tay Henry, Nur Reved, Dee Nicole, Gitanjali Goel, and Ann Lovatt, this special compilation explores how homeopathy addresses chronic conditions by getting to the root of the problem. Celiac Disease: Healing the Gut Tay Henry kicks off the episode by discussing celiac disease, an autoimmune condition triggered by gluten. Often misidentified as a simple food intolerance, celiac causes significant degradation of the gut. While removing gluten is essential, homeopathy acts as a powerful catalyst to heal the underlying damage and restore vital nutrient absorption, which is especially critical for developing children. Key Remedies Mentioned: Lycopodium (for intense bloating and gas immediately after eating) and China (for profound weakness following fluid loss). Histamine and Allergic Reactions Next, Nur Reved breaks down the body's histamine response. Histamine acts as a cellular alarm system, rushing blood to affected areas to flush out toxins (causing itching and hives). When this system overreacts due to environmental toxins, poor diet, or stress, conventional antihistamines simply block the release of histamine, often causing drowsiness and eventual dependency. Homeopathy takes a different approach: remedies like Histaminum work with the body, signaling it to calm down and remember how to naturally regulate its immune response. Panic Attacks: The Body's Alarm Bell Dee Nicole explains that a panic attack is the body's "last resort" to get your attention. It acts like an overly sensitive fire alarm, signaling deep, underlying anxiety or a chronic feeling of being unsafe. Often, the fear of having a panic attack becomes worse than the attack itself. Homeopathy works to break this cycle of fear, providing remedies that help the body manage the acute moment while simultaneously addressing the deep-seated root cause. Parasites and Miasmatic Susceptibility Gitanjali Goel sheds light on parasitic infections, noting that many people carry low-grade burdens for years without realizing it. Symptoms often present as fatigue, bloating, skin issues, or teeth grinding in children. She explains the concept of "miasms"—inherited patterns of susceptibility. If your body's "foundation" is weak, parasites can easily take hold. Homeopathy strengthens this foundation. Gitanjali also highlights how the lunar cycle (full moons) heavily influences parasite activity and symptom flare-ups. Psoriasis and Inherited Trauma Finally, Ann Lovatt explores the emotional roots of psoriasis. She notes that the disease often triggers at the site of a physical injury (like a cut or sunburn), but the true cause is typically deep emotional suppression or trauma. Ann poignantly describes psoriasis as the body developing a "thick skin" to protect against painful emotions. She shares how homeopathy looks beyond the physical, sometimes addressing inherited generational trauma to bring about true healing. Watch the full episodes featured in this special show: Celiac Disease, Gluten Reactions & Homeopathy with Tay Henry: https://www.youtube.com/watch?v=M9pT9Tn_AgU Rethinking Allergies and Autoimmune Disease with Homeopathy with Nur Reved: https://www.youtube.com/watch?v=1e_KGsYFjNM Understanding Fear, Healing Patterns & Finding Calm with Dee Nicole: https://www.youtube.com/watch?v=BqZD4zpd8A4 Parasites, Hidden Symptoms & Homeopathy with Gitanjali Goel: https://www.youtube.com/watch?v=gTcckwOnAOE Psoriasis & Homeopathy: Healing the Root Cause with Ann Lovatt: https://www.youtube.com/watch?v=EOQ4a2cAN4I   You can also subscribe to our podcast channels available on your favourite podcast listening app below: Apple Podcast: https://podcasts.apple.com/us/podcast/homeopathy247-podcast/id1628767810 Spotify: https://open.spotify.com/show/39rjXAReQ33hGceW1E50dk Follow us on our social media accounts: Facebook: https://www.facebook.com/homeopathy247 Instagram: https://www.instagram.com/homeopathy247 You can also visit our website at https://homeopathy247.com/

Description: "What is metabolic disease and why do I have it on top of psoriatic disease?" Hear dermatologist Dr. Ronald Prussick and registered dietitian Danielle Cahalan explore this collision of diseases and how you can take control to help reduce the impact of inflammation.           Join host Corinne Rutkowski as she discusses why metabolic disease occurs with psoriasis and psoriatic arthritis and what can be done to improve overall health with dermatologist and Vice Chair of the NPF Medical Board, Dr. Ronald Prussick from Washington Dermatology Center in Rockville and Frederick, MD, and Danielle Cahalan, a registered dietitian and coach with All Access Dietitians. Listen as they also discuss the four pillars of health, the latest evidence around use of the Mediterranean Diet with psoriatic disease, key nutrients that impact overall health from omega 3's, polyphenols, and fiber, to making small sustainable changes.  This episode offers information to help explain the connection between metabolic and psoriatic disease and what can be done to decrease health risks associated with both diseases through sustainable changes. Timestamps: (0:00)  Intro to Psoriasis Uncovered & guest welcome dermatologist Dr. Ronald Prussick and registered dietitiand and coach                  Danielle Cahalan.                                                                                              (1:27)  Definition of metabolic disease and why the risk is higher among those with psoriasis or psoriatic arthritis. (3:11)  How this bi-directional relationship impacts the management of psoriasis and psoriatic arthritis. (6:54)  The four pillars of health that can be used to reduce the risk of metabolic disease.   (11:17) Does an anti-inflammatory diet exist? (13:46) What is the Mediterranean diet and the foods that are typically included. (16:32) The impact of the Mediterranean diet on systemic inflammation, metabolic health, and severity of psoriatic disease. (21:03) The three types of healthy fats – what they are, how they work, and where to find them. (24:50) The high polyphenol Mediterranean diet from what that means to choosing nutrient dense, colorful foods. (28:04) The koebnerization of the gut microbiome and the impact of the Mediterranean diet and high fiber. (30:59) The DASH diet in combination with the Mediterranean diet lowers oxidative stress and inflammation. (33:14) Sustainability of the Mediterranean diet and flexing behavioral health changes long term.  (37:43) Start with small habit changes and then build from there to have an impact on your metabolic health.  Key Takeaways: ·       Research shows a bi-directional relationship between psoriasis and excess body weight leading to increasing severity of disease, decrease in treatment effectiveness, and the development of metabolic syndrome, a group of conditions which together raise the risk of coronary heart disease, stroke, and diabetes. ·       What you choose to eat can make an impact in managing inflammatory markers, metabolic health to increase insulin sensitivity, decrease high blood pressure, improve lipids and the gut microbiome, as well as support neuro protection and decrease cognitive decline. ·       Create small sustainable habits that make positive changes to your immune system and gradually work towards building a foundation that benefits your overall health. Guest Bios: Renowned dermatologist Ronald Prussick, M.D. is the Medical Director of the Washington Dermatology Center in Rockville and Fredrick, Maryland where he specializes in the treatment of psoriasis along with other diseases of the skin, hair, and nails with the latest technology and products. Dr. Prussick is also a Clinical Associate Professor in Dermatology at George Washington University in Washington, D.C.. Dr. Prussick has a research interest in the impact of diet on psoriatic disease and metabolic health. He first became interested after being involved in Dr. Joel Gelfand and Dr. Nehal Mehta's work in vascular inflammation trials using FDG-PET?CT scans to view systemic and cardiovascular inflammation associated with psoriatic disease. Dr. Prussick also participated in the development of the 2018 Dietary Recommendations for Adults with Psoriasis or Psoriatic Arthritis from the Medical Board of the NPF, which offered a review of studies addressing the impact of dietary interventions in people with psoriasis and psoriatic arthritis. Dr. Prussick is Vice Chair of the NPF Medical Board which provides clinical direction, treatment guidance, and provides education oversight to the organization and its Executive leaders. Danielle Cahalan, MS, RDN is a licensed and registered dietitian and coach with All Access Dietitians which offers virtual nutrition support services in AZ, CA, CO, CT, FL, IL, IN, MA, MO, MT, NJ, NY, NC, OR, PA, SC, TX, VA, WA, WI, and WY. All Access Dietitians infuses the science of motivation, habit formation, and sustainable behavior change into every session that addresses weight management and metabolic health, to women's health and digestive support. Danielle's primary focus during sessions is to help her clients find that intersection between enjoyment and satisfaction with their food choices that also support their health through sustenance. It's about finding that balance between feeling empowered, energized, and confident in the ability to make decisions that impact health, wellness, and longevity. Resources: "Mediterranean Diet Pyramid: Guidelines for Healthy Eating" © 2009 Oldways Preservation and Exchange Trust www.oldwayspt.org and UCSF Weill Institute for Neurosciences Memory and Aging Center. DASH Eating Plan (Dietary Approaches to Stop Hypertension). February 25, 2026. NIH (National Heart, Lung, and Blood Institute)  Mediterranean Diet and Patients With Psoriasis: The MEDIPSO Randomized Clinical Trial. AMA Dermatology . Dec. 1, 2025  The Mediterranean Diet as a Potential Solution to the Gut Microbiome Dysbiosis in Psoriasis Patients Journal of Psoriasis and Psoriatic Arthritis 2024 Jan 9.

La psoriasis pediátrica es una condición que no sólo afecta la piel, sino también se asocia a comorbilidades significativas y a una disminución de la calidad de vida de los niños y sus familias. En este episodio profundizamos en el tema con una experta en la materia, desde cómo se manifiesta la psoriasis pediátrica, sus potenciales causas y alternativas de tratamientos. Nos acompaña la Dra. Paula Luna desde Buenos Aires, Argentina. La Dra. Luna es dermatóloga y dermatóloga pediatra en el Hospital Alemán en Buenos Aires, Argentina, donde también dirige la beca en psoriasis y otras enfermedades inflamatorias. Se desempeña como secretaria general de la Sociedad Argentina de Psoriasis y de la Sociedad de Dermatología Pediátrica para América Latina. Después de completar su residencia en dermatología y de ejercer como jefa de residentes, la Dra. Luna realizó la subespecialidad de tres años en dermatología pediátrica en el Hospital Ramos Mejía de Buenos Aires. Instagram: @‌drapauluna ¿Tienes algún comentario sobre este episodio o sugerencias de temas para un futuro podcast?  Escríbenos a pediatrasenlinea@childrenscolorado.org.

The Derm on RheumNow podcast is a collection of Citations and Content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, other CTD skin disorders. dermatology drugs, biiologics, JAKs - their use, efficacy and side effects.  Features Dr. Jack Cush, Editor at RheumNow.com. Show Notes: Chinese target emulation trial of MDA-5+, dermatomyositis w/ ILD. 106 Rx w/ UPA & 328 w/ TOFA. 6-month lung transplantation-free survival 72% vs 67% (UPA v TOFA). UPA non-inferior to TOFA in MDA5+DM-ILD https://t.co/BBAfbM06AM In 2025 DTC TV ad spending by top 10 incr to $2.67 billion (up from $2.1 B). Rheum Drugs in top 3: 1. Skyrizi $440 million 2. Tremfya $431 M 3. Rinvoq $376 M https://t.co/EsWgUqUy9Z 2. Dermatology Salaries 2025 – Dermatology is top 10 at $448K according to Medscape; expected to go down -1% in 2026; derms made up 2% of survey group 37K MDs 3. Itch is common in Scleroderma (SSc) and not related to Dz duration. Study of 2173 Pts (~20K itch assessments), 87 F; mean age 55 yrs; 40% w/ diffuse SSc. Itch (moderate 4/10) seen in ~35% at all times https://t.co/QnT8d0xA5Z 4. Asia-Pacific Lupus study of Mucocutaneous activity (MC-A) in 4102 SLE pts. 36% had MC-A (rash 1055; alopecia 731; m ulcers 352); 15% persistently. MC-A assoc w/ W, smoking, +serologies, vasculitis, myositis, serositis, nephritis, NP-SLE https://buff.ly/D5fXJdY 5. Predictors of Calcinosis Cutis in Systemic Sclerosis   6. AFFINITY Study - Combination Biologic Therapy in PsA A pilot trial assessed the efficacy and safety of the guselkumab+golimumab (COMBO) combination versus GUS monotherapy in active PsA (failing a prior tumor necrosis factor inhibitor (TNFi-IR) and showed superiority in ACR 50 https://t.co/f2CB8FnZMB 7. AAD 2026 Annual Mtg presents new data on another TYK2 inhibitor. In 2 phase 3 RCTs (ONWARD1 ONWARD2) envudeucitinib was superior to placebo & apremilast in 1700 plaque psoriasis pts https://t.co/DPlzDw5m7N 8. Among 1074 #PsA tested annually, RF positivity was found in 16.1% overall (5.1% RF+ at baseline). RF+ rediced odds of MDA (OR 0.53) w/ incr risk of bDMARD discontinuation (OR 2.65) https://buff.ly/BsM7NKQ 9. The National Psoriasis Foundation Primer on GLP-1 Receptor Agonists in Psoriasis - Review 10. Ixekizumab With Tirzepatide Efficacy in Obese Psoriatic Arthritis 11. Brepocitinib in Dermatomyositis

Join Dermatology Times for a conversation with Liza O'Dowd, MD, vice president of immunodermatology and respiratory disease areas at Johnson & Johnson, recorded at the 2026 AAD Annual Meeting. Dr. O'Dowd discusses one-year efficacy and safety data for icotrokinra (Icotyde), the newly approved once-daily oral peptide IL-23 receptor antagonist for moderate to severe plaque psoriasis in adults and adolescents 12 and older. At 52 weeks, approximately 50% of adult patients achieved total skin clearance, rising to 60% in adolescents enrolled in the LEAD study. Adverse event rates through one year remained within 1.1% of placebo, with no mandatory tuberculosis pre-screening required. Dr. O'Dowd also addresses icotrokinra's anticipated role as a first-line systemic therapy and offers practical reassurance for clinicians considering this novel agent for their patients.For more content from Dermatology Times, visit https://www.dermatologytimes.com/

Bloating after meals, constipation, or sudden urgency to run to the bathroom are often brushed off as normal, but they can be signs of irritable bowel syndrome. In this episode, we unpack why IBS is often treated as a label to justify medications rather than a sign pointing you to issues brewing under the surface.Joining me today is Dr. Izabella Wentz, an integrative pharmacist, thyroid expert, and bestselling author known for helping people uncover the root causes of chronic health issues.So if you have tried elimination diets, probiotics, or leaky gut supplements without lasting relief, this conversation is for you!⭐️Mentioned in This Episode:- My FAV gut support

In this episode, Drs. Nilasha Ghosh and Anne Bass discuss immune-related adverse events from immune checkpoint inhibitors, focusing on psoriasis and psoriatic arthritis. They review early clinical recognition, epidemiology, and findings from a multicenter observational study evaluating apremilast, including patient characteristics, outcomes, and key limitations. The conversation also highlights insights from the HSS Checkpoint Inhibitor–Associated Arthritis Registry, the need for greater precision in rheumatology, and practical perspectives on mentorship and career development for emerging clinician–scientists.  Use of Apremilast for the Treatment of Immune Checkpoint Inhibitor Psoriasis and Psoriatic Arthritis 

With so many options available to treat psoriasis and psoriatic arthritis across age groups, treatment selection must be made on an individualized basis. DEF Biologic & Small Molecule CME Bootcamp faculty members Joe Gorelick, MSN, FNP-C, Kara Gooding, MMS, PA-C, and Andrea Nguyen, DMSc, MPAS, PA-C discuss case presentations. Plus, an update on PRP from Gilly Munivalli, MD and rosacea tips from Wendy Cantrell, DNP, CRNP.Like what you're hearing? Want to learn more about the Dermatology Education Foundation? Explore assets and resources on our website.

00:00 – Intro & welcoming Catherine from @myproper.nutrition 02:00 – The rheumatoid arthritis case that sparked it all 02:45 – The autoimmune trigger foods: eggs, dairy, nightshades, nuts, seeds, grains 03:10 – Elimination vs. rebuilding: why meat stock and bone broth are foundational 04:30 – Why reintroducing eggs too early wrecks progress 05:25 – Meat stock vs. bone broth: what's the actual difference? 06:30 – When even vegetables are reactive 07:40 – The $6,000 supplement stack problem 09:00 – Why whole foods beat isolated vitamins every time 10:30 – Fruit, training, and glucose response 12:00 – Creatine, kidney failure & the case against synthetic supplementation 14:20 – Getting creatine naturally (sardines, meat, broth) 15:50 – Organic vs. non-organic: why you eat less when food is nutrient-dense 19:00 – The reintroduction pyramid: building tolerance back 21:30 – Hashimoto's, under-eating & the Netherlands tap water story 23:30 – Helping long-term carnivore & paleo clients find their "why" 29:00 – Deep dive: Hashimoto's protocol, stress, circadian health 31:00 – Michelle's IVF story — preparing the body for pregnancy 32:00 – Nutrient loading through pregnancy & avoiding postpartum issues 35:00 – Organ meats, bone marrow & natural collagen 37:00 – The supplement industry vs. nature's pharmacy 39:00 – The vegan paradox: "perfect bloods" but failing bodies 41:00 – Reversing meds: the rheumatoid arthritis client's journey 44:30 – Food families, reactivity & personalised base diets 46:00 – Why nightshades, lectins and anti-nutrients matter 48:00 – Quantity matters: the spinach & almond reaction test 50:15 – The carnivore trend — why stripping vegetables isn't the answer 52:10 – The carnivore doctor turning yellow (beta-carotene / liver signs) 54:00 – Environment, stress & relationships as healing accelerators 57:00 – Psoriasis remission & the reintroduction checkpoint 59:00 – Catherine's own story: endometriosis, PCOS, eczema 1:02:00 – Walking away from her nutrition degree & seed-oil dogma 1:04:00 – Finding purpose, prayer & mission-driven practice 1:06:00 – Training practitioners in the Proper Nutrition method 1:07:00 – Hydration: why your perfect diet still fails without water 1:08:30 – Brutal honesty on the mental/emotional level 1:11:00 – Chris Kresser, "nutrivore" & the parasite-from-Bali story 1:12:30 – Parasite cleanses that keep failing — and why 1:14:00 – Plantar fasciitis, barefoot movement & evolutionary load 1:15:30 – Why pregnant women get back pain (atrophied postural muscles) 1:16:00 – Catherine's closing message: start small, trust food 1:17:45 – Where to find Catherine & wrap-up

Description: Coping with psoriasis can be challenging when your routine changes. Hear NPF Youth Ambassadors Aditi, Alyssa, and Pierce offer what they do to overcome such challenges when out of their routine.            Join host Kaleigh Welch as she discusses tips for coping with changes that occur when traveling to visit family or friends, going on vacation, camping, or a change in schedule with three amazing NPF Youth Ambassadors Aditi, Alyssa, and Pierce who live with psoriasis. Hear their story from challenges with their initial diagnosis, struggles with insecurities, whether they choose to inform others, and what they do to manage their disease and stress while living their life with confidence to pursue their chosen activities  no matter if their routine changes.  This episode features how 3 NPF Youth Ambassadors overcome challenges when out of their routine and how they respond while managing their psoriasis.   (0:00) Intro to Psoriasis Uncovered & welcome to guests Youth Ambassadors Aditi, Alyssa, and Pierce. (0:55) Overcoming challenges from diagnosis, finding the right treatment, to making choices impacted by living with psoriasis.        (5:44) Tips for what to do and pack when traveling for activities that disrupt the usual routine. (10:11) Keeping the skin moisturized can be a challenge but find a routine and product that works. (12:38) Preparing for potential triggers that could initiate the Koebner phenomenon and psoriasis. (13:33) Managing the impact of stress when out of the routine or traveling. (16:20) Alyssa's approach to managing fatigue. (16:53) The impact of diet and exercise when managing psoriasis. (18:47) Telling others about psoriasis when staying at a friend's house or hotel. (23:36) Our number one recommendation for when being out of your routine.  (25:39) Be confident about who you are and trust you'll find the right treatment and routine for your psoriasis. Key Takeaways: ·       Being out of your normal routine whether traveling on vacation or for work, camping, staying at a hotel or with family or friends can present challenges to managing your psoriasis.   ·       Preparing in advance by anticipating medication or over-the-counter needs, telling others, and asking for help can reduce the impact of challenges due to a change in routine.   ·       Be confident about who you are, find a treatment that works, and learn to live successfully with your psoriasis.   Guest Bios: Aditi enjoys Carnatic singing, violin, figure skating, and participating in Model UN where students debate global issues, learn diplomacy, international relations, and public speaking. Aditi was diagnosed with psoriasis at 10 years old and has used topicals to manage her disease along with diet, exercise and stress management. Prior to becoming a Youth Ambassador she had never met anyone with psoriasis. She plans to pursue a career in dermatology.  Alyssa is relatively new to the NPF Youth Ambassador program, joining in 2025 to connect with others who also live with psoriasis. Her diagnosis process was challenging and eventually she was diagnosed with guttate psoriasis after being improperly diagnosed and given treatments that didn't fully clear her psoriasis. This experience changed her life both physically and emotionally. Alyssa is a busy student-athlete serving as a member of her school's varsity cheer team and being a star pitcher for her school's softball team.  Pierce connected with NPF right after being diagnosed with moderate to severe plaque psoriasis in 2024 which covered over half of his body. Together with his mother they learned more about the disease and management with various treatment options from NPF, quickly learning what worked and what didn't. Per Pierce "it was horrible dealing with it for a while because I couldn't hide the plaques."  After facing challenges with step therapy and eventually traveling to the Mayo Clinic he found the treatment he needed to help clear his skin. Pierce is very active in golf playing at least 5 days a week. He currently plays for his high school team, the Louisiana Junior Golf Tour, and the American Junior Golf Association (AJGA).  Pierce also became a Youth Ambassador to meet others with psoriatic disease. Resources: -Meet other teens who have psoriatic disease. Become a Youth Ambassador -"Traveling Near and Far With Psoriatic Disease" podcast episode. -"Moisturizing Sensitive Skin" Advance Online. June 11, 2025. 

If there are five people in a room with eczema, they're probably all dealing with it for completely different reasons.And that's something we don't talk about enough.Eczema, acne, psoriasis… these are rarely just skin issues. They're often a reflection of what's happening inside the body, particularly in the gut.So instead of just asking what to put on your skin, this episode is about asking a better question. What's actually driving this underneath?My guest today is Farzanah Nasser, a registered nutritionist and certified functional medicine practitioner specialising in gut health, immune health and chronic skin conditions.She works with people every day, dealing with long-standing skin issues using a practical, gut-first approach.She's also the author of “The Everyday High-Fibre Plan”, full of simple, gut-friendly recipes… including those cookies on the table if you're watching on YouTube

It probably doesn't surprise you that HS (hidradenitis suppurativa) is much more than just a skin condition. There is an increasing body of research showing how HS is linked to immune dysfunction, gut health, liver problems, hormone imbalances, and so much more that often goes overlooked in conventional medical care.In this episode, I'm diving into the links between Hidradenitis suppurativa and autoimmune disease, liver health, thyroid dysfunction, and gut health, so you can spot red flags and get help sooner!⭐️Mentioned in This Episode:- See all the references

Dermoscopy master class - with Dr. Michael Christopher! [⁠article⁠]The plumage sign in dermoscopy: pigmented SCCis [⁠article⁠] Highlights from the AAD -Icotrokinra for psoriasis [⁠article⁠] Learn more from Dr. Christopher! Instagram: @michael_christopher_mdCheck out Luke's Urticaria CME experience! ⁠aaaaicsu.gathered.com/invite/KQe1wPZbJY⁠ Learn moreabout the U of U Dermatology ECHO model! ⁠physicians.utah.edu/echo/dermatology-primarycare⁠ Want to donate to the cause? Do so here!Donate to the podcast: ⁠⁠uofuhealth.org/dermasphere⁠⁠Check out our video content on YouTube:⁠⁠www.youtube.com/@dermaspherepodcast⁠⁠and VuMedi!: ⁠⁠www.vumedi.com/channel/dermasphere/⁠⁠The University of Utah's DermatologyECHO: ⁠⁠⁠physicians.utah.edu/echo/dermatology-primarycare⁠⁠ -Connect with us!- Web: ⁠⁠⁠dermaspherepodcast.com/⁠⁠⁠ - Twitter: @⁠DermaspherePC⁠- Instagram: dermaspherepodcast- Facebook: ⁠⁠www.facebook.com/DermaspherePodcast/⁠⁠- Check out Luke and Michelle's other podcast,SkinCast! ⁠⁠⁠healthcare.utah.edu/dermatology/skincast/⁠⁠⁠ Luke and Michelle report no significant conflicts of interest… BUT check out our friends at:- ⁠Kikoxp.com ⁠(a social platform for doctors to share knowledge)- ⁠⁠⁠www.levelex.com/games/top-derm⁠⁠⁠ (A free dermatology game to learn more dermatology!

Dermoscopy master class - with Dr. Michael Christopher! [article]The plumage sign in dermoscopy: pigmented SCCis [article] Highlights from the AAD -Icotrokinra for psoriasis [article] Learn more from Dr. Christopher! Instagram: @michael_christopher_mdCheck out Luke's Urticaria CME experience! aaaaicsu.gathered.com/invite/KQe1wPZbJY Learn moreabout the U of U Dermatology ECHO model! physicians.utah.edu/echo/dermatology-primarycare Want to donate to the cause? Do so here!Donate to the podcast: ⁠uofuhealth.org/dermasphere⁠Check out our video content on YouTube:⁠www.youtube.com/@dermaspherepodcast⁠and VuMedi!: ⁠www.vumedi.com/channel/dermasphere/⁠The University of Utah's DermatologyECHO: ⁠⁠physicians.utah.edu/echo/dermatology-primarycare⁠ -Connect with us!- Web: ⁠⁠dermaspherepodcast.com/⁠⁠ - Twitter: @⁠DermaspherePC⁠- Instagram: dermaspherepodcast- Facebook: ⁠www.facebook.com/DermaspherePodcast/⁠- Check out Luke and Michelle's other podcast,SkinCast! ⁠⁠healthcare.utah.edu/dermatology/skincast/⁠⁠ Luke and Michelle report no significant conflicts of interest… BUT check out our friends at:- ⁠Kikoxp.com ⁠(a social platform for doctors to share knowledge)- ⁠⁠www.levelex.com/games/top-derm⁠⁠ (A free dermatology game to learn more dermatology!

Kelly Cordoro, MD interviewed by Robert Smith, MD, FAAD

Eczema, psoriasis, acne and other chronic illness (even ones that aren't skin related) may be more than just a skin condition. In this episode, we explore how liver detox pathways Phase 1, Phase 2, and Phase 3 influence skin health, and how nutrient deficiencies or excesses can trigger inflammation, histamine buildup, and eczema flares. Learn which vitamins, amino acids, and supplements may be worsening your symptoms by overstimulating detox pathways, and how to properly support the gut liver skin axis for long term healing.Work with me: https://holisticspring.com/contactInstagram: www.instagram.com/wholistichomeopath

Persistent drool rash can be more than just a messy phase. In this episode, we explore how red, irritated cheeks, especially when they flare at certain times of day, may be early clues that a baby's skin barrier is struggling and that deeper eczema-related issues could be developing.We also unpack how signs like cradle cap, colic, diaper rash, flushing with foods, and mucus in stools can fit into a bigger picture. Tune in to learn how to tell the difference between a drool rash, an eczema flare, and a possible allergic reaction, so you can feel more confident about what your baby's skin may be trying to tell you.My guest, Jennifer Brand, MS, MPH, CNS, LDN, is a clinical nutritionist who helps babies and children with chronic rashes get to the root causes of their skin issues. Known for her pediatric skin-focused approach, she is passionate about helping families support healthy skin through her signature method, Rashes Be Gone.⭐️Mentioned in This Episode:- See all the references

Description: Learn why advocating for care is crucial when moderate to severe plaque psoriasis develops at a young age or in high-impact sites, and how advanced biologic therapies can offer effective solutions for those that may be undertreated. Join moderator Kaitlin Walden, patient advocate Carolyn, and dermatologist Dr Candrice Heath as they discuss the realities of living with moderate to severe plaque psoriasis at a young age, as well as adult patients with plaque psoriasis in high-impact sites, like the scalp, nails, and face. Carolyn shares her personal journey with moderate to severe plaque psoriasis and how it has continued from childhood into adulthood, while Dr Heath offers insights to help caregivers and patients navigate treatment approaches, including when and how a biologic therapy may be helpful. This episode addresses challenges associated with living and treating moderate to severe plaque psoriasis in children and adults. This episode is sponsored by Johnson & Johnson. Please see Important Safety Information and full Prescribing Information for the product mentioned in this episode. Timestamps: ·       (0:23) Intro to Psoriasis Uncovered and guest introductions from dermatologist Dr. Candrice Heath and Carolyn, a patient advocate living with plaque psoriasis and psoriatic arthritis. ·       (1:22) Information about, and pivotal data for, TREMFYA® (guselkumab), a biologic used to treat adults and children 6 years and older who weigh at least 88 lbs or 40 kilograms with moderate to severe plaque psoriasis. ·       (3:48) Living with psoriasis as a child can be difficult with challenges in being diagnosed correctly and receiving appropriate treatment.  ·       (6:17) A dermatologist's view of children and adolescents living with plaque psoriasis including in high-impact sites. ·       (8:14) It's important to advocate for yourself and the best possible care. ·       (9:37) Open communication with your dermatologist helps identify the best possible treatment plan, which is dependent on several factors including the availability of new treatment options. ·       (12:05) Carolyn's biggest challenge is managing her psoriasis and then psoriatic arthritis. ·       (14:20) Results of the SPECTREM clinical trial addressing treatment of adults with moderate plaque psoriasis in high-impact sites. ·       (17:38) Find the support and information you need to find the right treatment. ·       (21:48) Important Safety Information about TREMFYA® (guselkumab).   Key Takeaways: ·       Plaque psoriasis can be challenging both physically and emotionally for children and adults – especially when high-impact site involvement (such as the face, scalp, armpits, and groin) is present. ·       Individual treatment plans vary and are based on several factors, including the severity of psoriasis, dosing schedule, cost, or route of administration. Finding the right treatment for plaque psoriasis is a collaboration between a dermatologist, the patient, and/or family (should the patient be a child). ·       A number of medicines that treat plaque psoriasis from the inside out, including biologics, are now available for children and adults. Such treatment options are continuing to expand. Guest Bios: Candrice Heath, M.D. is a highly respected triple board-certified dermatologist who sees both children and adults at Howard University Hospital in Washington DC where she is also an Associate Professor in the Department of Dermatology. She is board-certified in dermatology, pediatrics, and pediatric dermatology.  Dr Heath is a nationally recognized speaker, pediatric and adult dermatology clinical researcher, and has held a variety of leadership roles including Chair for the Pediatric Dermatology Research Alliance (PeDRA), Skin of Color and Pigmentary Disorders Focused Group, Skin of Color Society National Secretary-Treasurer, and American Academy of Dermatology Diversity Committee member. Her clinical, research, and teaching interests are shaped by insights gained from her unique practice filled with both children and adults in addition to her passion for exploring the intersection of dermatology and social science.  Carolyn Pugh is a patient advocate and volunteer with the National Psoriasis Foundation who lives with psoriasis and psoriatic arthritis. Carolyn was diagnosed with psoriasis at age 11 after being misdiagnosed and offered treatments that didn't work. Once she was diagnosed with plaque psoriasis some of the initial treatments were difficult and unsustainable. Over the years she has learned to advocate for her own self-care and feels her personal experiences can help empower other adults and parents. Resources: ·       Learn more about treatment options for children and adolescents at Our Spot for Youth and Parents   ·       For more information about psoriasis in high-impact sites

Laura bravely shares the story that has shaped her life in so many ways. Psoriasis, endometriosis, and multiple hospitalizations with a layer of MTHFR gene mutation underneath. Watch to see how Laura has mastered her own health, her own path, and her journey forward for herself and her family.00:00 - Intro00:39 - Laura's story - psoriasis, psoriatic arthritis, and more.01:44 - Stage 4 endometriosis02:46 - Fertility03:15 - First episode of Multiple Sclerosis (MS)04:35 - Crippling fatigue05:38 - Finding a functional doctor07:42 - MTHFR and folic acid08:52 - Heavy metal detox09:55 - Laura and Dr. Amy are twinning!11:09 - High-dose vitamin D12:54 - Learning to trust your body14:26 - Laura's kids17:12 - Vitamins should be healthy, but...18:19 - The impact of accidentally eating fortified foods18:51 - How MTHFR is like the Bin Man20:02 - The decision to support her immune system instead of suppressing it21:38 - Psoriasis symptoms as a gauge of health25:06 - Medicine is still not good with women's hormones25:52 - Advocating for yourself in medicine29:00 - If I'd known about MTHFR earlier33:04 - Laura's Podcast: The Understanding You PodcastThanks so much for watching! I have so many other resources for you. Here is the full-length version of this interview on YouTube: https://youtu.be/28NcHb2twF0Check out the website for lots of FREE stuff:WEBSITE: https://tohealthwiththat.com/ Order Dr. Amy's book MTHFR Easy: Get Healthy For Life: https://amzn.to/47tT31YPaperback and audiobook versions are coming soon.This story was shared graciously and generously with permission to post on the podcast, Youtube, and in print if that happens in the future.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we explore the latest news and trends shaping this dynamic industry.Significant strides have been made recently, particularly with the FDA's approval of J&J and Protagonist Therapeutics' novel psoriasis medication, Icotyde. This once-daily oral treatment could disrupt a market dominated by injectable therapies. The convenience of oral administration is likely to improve patient compliance and drive substantial sales, marking a pivotal moment in psoriasis treatment. The Phase 3 ICONIC trial demonstrated substantial efficacy over existing treatments like Bristol Myers Squibb's Sotyktu. This trend towards more patient-friendly options is indicative of a broader industry shift and signifies Protagonist's entry into competitive immunology markets.Turning to biosimilars, Sandoz has expanded its partnership with Samsung Bioepis to commercialize up to five biosimilars, including a version of Takeda's Entyvio. This collaboration highlights the industry's growing reliance on biosimilars as affordable alternatives to branded biologics. Amidst pricing pressures and a global demand for accessible medications, such strategies are becoming increasingly vital.In an ambitious venture, TerraPower Isotopes, backed by the Gates Foundation, is investing $450 million in a plant for producing actinium-225, a rare isotope used in radiopharmaceuticals. This move positions TerraPower as a leader in supplying crucial ingredients for targeted cancer therapies—an area that promises advancements in precision medicine by offering targeted treatments with fewer side effects.Regulatory landscapes are evolving too, with the FDA and NIH committing $150 million towards alternatives to animal testing in drug development. This initiative emphasizes ethical scientific practices and leverages innovative technologies like organ-on-chip systems. Such regulatory support is essential for speeding up drug development while ensuring safety standards remain high.Stem cell therapy also sees promising developments with Aspen Neuroscience's treatment for Parkinson's disease. After one year, all treated patients showed symptom improvement, paving the way for pivotal Phase 3 trials. These results underscore the transformative potential of regenerative medicine in tackling neurodegenerative disorders.As the industry evolves, it faces challenges such as looming patent expirations and intensified competition. These pressures are prompting companies to innovate and reconsider strategies for existing product lines. In response to these challenges, strategic realignments are becoming more common.Meanwhile, Indiana's plan to create 100,000 jobs through a $1 billion strategy highlights regional efforts to establish hubs for life sciences innovation, illustrating the broader economic impact of the biopharma sector.In parallel news, Xaira Therapeutics has raised an impressive $1 billion to leverage AI for drug discovery in inflammatory and immunological research. This underscores growing reliance on AI technologies to accelerate drug development timelines. Crossbow Therapeutics reached a significant milestone by securing $77 million in Series B funding to advance its T-cell engager technology—a promising approach in immuno-oncology that harnesses the immune system against cancer cells.Despite these advancements, economic pressures continue to challenge some companies. Layoffs at Gossamer Bio and Bicycle Therapeutics highlight sector volatility and the need for strategic adaptability. Corporate governance remains under scrutiny as Moderna's CEO compensation package reveals executive priorities amidst revenue shortfalls. Meanwhile, GSK faces criticism over its management practices concerning Flovent, which raises ethical concerns about pricing strategies.In cardiovascular care, Support the show

Ep 92 | Cuts, burns, bug bites, rashes—most of us have a different product for every problem in our medicine cabinet. But what if natural first aid worked better with fewer, more versatile solutions?In this episode of Homes That Heal, Jen sits down with Jodi Scott, co-founder of Green Goo, to talk about natural first aid, plant-based remedies, and why simplifying your first aid kit can support the body's natural healing process.Jodi shares how a moment during pregnancy—reading the ingredient label on a common first aid product—sparked a deeper search for herbal remedies and plant-based alternatives for everyday skin care. What began as herbs growing on a family farm eventually became Green Goo, a company focused on simple, multi-use products designed to support cuts, burns, bug bites, and other everyday skin concerns.If you've ever opened your medicine cabinet and felt overwhelmed by expired tubes, complicated ingredients, or products that only solve one small problem, this conversation offers a refreshing perspective on simplifying your first aid kit and working with your body's natural defenses.

Topical steroid withdrawal syndrome is finally getting the serious attention it deserves. In this episode, talk about the first published criteria to help doctors diagnose TSW (also known as red skin syndrome) and why it will help validate the experience of people who have been dismissed, misdiagnosed, or told they simply have severe eczema. We also dig into the growing gap between patient experience and conventional dermatology, and why that disconnect has left so many people searching for answers on their own.Dr. Olivia Hsu Friedman, DACM, L.Ac, Dipl.OM, joins me to discuss this and more! She is the owner of Amethyst Holistic Skin Solutions and brings extensive training in acupuncture, Chinese medicine, and dermatology to this timely discussion.⭐️Mentioned in This Episode:- See all the references

Hear leading dermatologist Dr. E. James Song and patient advocate Ana Rinck share their perspectives on the use of biosimilars to manage psoriasis and psoriatic arthritis. The use of biosimilars is growing with 24 currently on the market and more on the way for the treatment of psoriasis and psoriatic arthritis. What does this mean for you? Find out as we explore the use of biosimilars, the impact of interchangeability, what it's like switching to a biosimilar, and what questions to ask your health care provider with leading dermatologist and NPF Medical Board member Dr. E. James Song, Director of Clinical Research at Frontier Dermatology Partners, and patient advocate Ana Rinck who currently uses a biosimilar to treat her psoriasis and psoriatic arthritis.   The intent of this episode is to offer an update on the use of biosimilars and to hear the experience of those who have used biosimilars to manage psoriatic disease. This episode is sponsored by Organon. Timestamps: (0:00) Intro to Psoriasis Uncovered and guest welcome to dermatologist Dr. E. James Song, Director of Clinical Research and Co-Chief Medical Officer, Frontier Dermatology, and patient advocate Ana Rinck, who presents her experience with using a biosimilar to treat psoriasis and psoriatic arthritis.  (0:58) Definition of what is a biosimilar in comparison to a biologic which is also referred to as the original bio-originator or reference product.   (3:10) What biosimilars are available and how they are used. (4:35) The term interchangeable and what it means for use of a biosimilar. (5:46) Ana's diagnosis to treatment options starting with use of topicals to ultimately use of a biosimilar.  (7:57) Treatment discussion and choices when faced with diminishing effectiveness within a class of medications. Should a biosimilar be considered as an option?                                                                                                                                                                (9:50) Questions to consider when there's a change in treatment. (10:57) FDA announcement to simplify the development process for biosimilars and what that means for the future use of biosimilars. (13:55) What to consider when thinking of a biosimilar as a treatment option and where to find help when needed.     (14:53) The hope and equity of access that biosimilars represent is here for the appropriate individual. Key Takeaways: ·       A biosimilar is an FDA-approved biologic product that behaves and functions like a brand biologic treatment which is also called the reference product or bio-originator. There are no clinically meaningful differences between biosimilars and their reference product.  ·       The FDA has approved several biosimilars for the treatment of psoriasis and psoriatic arthritis. Some have been identified as interchangeable which means a biosimilar could be substituted for a reference product without a health care provider's approval pending state legislative rules.    ·       Don't be afraid to ask questions or access resources to assist with preparing for a medication change should that change be initiated either by yourself, your healthcare provider, or your health insurance company.    Guest Bios:   E. James Song, M.D. is a nationally recognized dermatologist and clinical researcher who is also a Clinical Instructor at the University of Washington. Dr Song is recognized as a key opinion leader in treating psoriasis and atopic dermatitis. He is actively involved in the development of new therapies for dermatologic disease and has firsthand experience with treatments before they come to market. Dr. Song has been published extensively in peer review journals and regularly participates in meetings both as a lecturer and attendee.  He is also a Medical Board member of the National Psoriasis Foundation. He believes that the best health outcomes come from shared decision making between the patient and physician. Dr. Song strives to help patients understand not only their condition, but all their treatment options.  Ana Rinck is a patient advocate and volunteer for the National Psoriasis Foundation. She developed psoriasis in 2009 following symptoms she noticed for a few years which proved to be challenging to diagnose. She managed for many years on topicals and intralesional injections. In 2018 she was diagnosed with psoriatic arthritis and started use of a biologic realizing she needed to protect her joints from further damage. She now uses a biosimilar to manage her psoriatic disease. Ana owns her own private consulting business and is an Operations and Project Manager.  Resources: -Learn more about biosimilars, interchangeability, and state substitution rules.   -Armstrong A, Callis Duffin K, Feldman S, Glick B, Kalb R, Reddy S, Schwartzman S, Yamauchi P, Calabrese C, Cordoro K, Desai S, Gladman D, Han G, Hawkes JE, Hsu S, Kircik L, Koo J, Kreuger GG, Lebwohl M, Leonardi C, Lewitt GM, Liao W, Liu C, Markenson J, Merola JF, Orbai A, Prussick R, Richardson V, Soung J, Van Voorhees AS, Wallace E, Weinberg J, Wine Lee L, Harris J, Koons S, Howard L. Position Statement on the Use of Biosimilars for Psoriasis and Psoriatic Arthritis. National Psoriasis Foundation Medical Board. 2023. -If you need help finding a dermatologist near you contact the NPF's Patient Navigation Center for assistance.   

Episode 26-10 15 Habits That Help Your Body Heal If I could wave a magic wand over you and make one health issue disappear, what would you want it to be? Headaches? Back pain? Depression? Anxiety? Cancer? Diabetes? Chronic Fatigue? Diverticulitis? Infertility? Psoriasis? Whatever your answer... know this: I don't have a magic wand, but I DO have something that can help your body heal. Actually, it's not a "something"… it's many things. Fifteen to be exact. Yes, on this episode I share with you 15 habits that I believe can help your body heal. 15 natural "Vehicles" that will help get you from your current health status (your Point A) to your desired health status (your Point B). So, if you're interested in having your body heal itself naturally... give this episode a good listen. And then, be sure to share it with a friend. Thanks! ———————- Want to learn more? Continue the conversation regarding this episode, and all future episodes, by signing up for our daily emails. Simply visit: GetHealthyAlabama.com  Once there, download the "Symptom Survey" and you will automatically added to our email list. ———————-               Also, if you haven't already, we'd appreciate it if you'd subscribe to the podcast, leave a comment and give us a rating. (Thanks!!!)                

 * This podcast is for informational and educational purposes only. It is not intended to diagnose or treat any disease. Please consult with your health care provider before making any health-related changes.

The Derm on RheumNow podcast is a collection of Citations and Content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, other CTD skin disorders. dermatology drugs, biiologics, JAKs - their use, efficacy and side effects.  Features Dr. Jack Cush, Editor at RheumNow.com.  SHOW NOTES FDA sent a complete response letter to AstraZeneca on their application (BLA) for anifrolumabs (Saphnelo) subcutaneous use in SLE. Despite a positive TULIP-SC trial & EU approval of SC-anifrolumab, FDA & sponsor still have to work things out. CRL reasons are unknown https://t.co/3dNwEyolrj Review of Calcinosis Cutis - Surgical intervent. most effective (excision, curettage, laser ablation, etc). Medical measures inconsistently, partially effective, best if used early & localized (CCB, TCN, probenecid, immunomodulation, biologics, colchicine, NA thiosulfate, & JAKi https://t.co/rv0hQBv6nX Systematic Review of Targeted Rx for Systemic Sclerosis: from 32 RCTs & 2036 pts Rx w/ 23 targeted agents. Guselkumab had greatest effect on mRSS, followed by tofacitinib, inebilizumab, & baricitinib. For FVC, B-cell Rx (belimumab, RTX) had highest efficacy https://buff.ly/vHOSRws Dermatomyositis outcomes w/ 2475 pts (claims) & 1196 pts (EHR). Half had myositis panels & 35% had + MSAbs. Steroid use common in 69% & 74%. HCQ, MTX, MMF. Outocmes (per 1000PYs) wereL all-cause hospitalisation 92, malignancy 15.3, ILD 6.4, and myocarditis 2.1 https://t.co/DJqKGNGX76 Danish DERMBIO registry of psoriasis pts Rx w/ biologics. Among 3790 bionaive pts ustekinumab had best 1-5 yr survival vs (ADA & SEC). In 3403 bioexperienced pts, bimekizumab, guselkumab, & risankizumab had highest 2-year drug survival rate. https://t.co/TInyLPMYkb Real-world study of 1202 #PsA pts shows that secukinumab retention rates were lower w/ smoking (79%/73%/72% in never/former/current smokers) but not w/ obesity (72%/77%/77% in normal/overweight/obese), Adh HR signif. higher w/ former (1.32) & current smokers (1.27)   https://t.co/1REWmod73W Together PSO Trial - Combination Ixekizumab and Tirzepatide Today Lilly announced top line results of the TOGETHER-PsO open-label, Phase 3b trial demonstrating the significant benefits of concomitant ixekizumab (IXE: an IL-17A inhibitor) and tirzepatide (TIR: GLP-1agonist) over https://t.co/YWCjN2NyGM

High cholesterol in menopause and perimenopause is shockingly common, and many women feel blindsided by sudden spikes in cholesterol, blood pressure, or even blood sugar in their 40s. Perimenopause isn't only about hot flashes and mood swings. Hormonal shifts can quietly influence your cardiovascular system, changing the story your labs are telling and leaving you asking, “What changed?”Joining me is Dr. Eve Henry, board-certified in Internal and Integrative Medicine and founder of Eve Henry MD. She brings deep expertise in personalized medicine and longevity science to help you understand what's happening and how to support your healthspan for the long run.⭐️Mentioned in This Episode:- See all the references

With a carnivore diet, Phillip improved over 30 years of skin issues including eczema, severe plaque psoriasis, palm and plantar psoriasis, and scalp psoriasis. Phillip also improved his pre-diabetes. Instagram: https://www.instagram.com/mrphillipwin/ TikTok: https://www.tiktok.com/@mrphillipwin X: https://x.com/MrPhillipWin Timestamps: 00:00 Diet's role in autoimmune health 04:49 Topical steroid concerns in dermatology 09:49 Medication concerns and side effects 12:43 Psoriasis treatment self-discovery 14:49 Persistence with psoriasis treatment 17:49 Carnivore diet benefits and downsides 20:19 Health concerns and cultural food 24:02 Dairy tolerance and eczema 29:28 Biologics push for psoriasis treatment 31:11 Drug cycle and muscle loss 35:01Overcoming chronic illness Join Revero now to regain your health: https://revero.com/YT Revero.com is an online medical clinic for treating chronic diseases with this root-cause approach of nutrition therapy. You can get access to medical providers, personalized nutrition therapy, biomarker tracking, lab testing, ongoing clinical care, and daily coaching. You will also learn everything you need with educational videos, hundreds of recipes, and articles to make this easy for you. Join the Revero team (medical providers, etc): https://revero.com/jobs ‪#Revero #ReveroHealth #shawnbaker  #Carnivorediet #MeatHeals #AnimalBased #ZeroCarb #DietCoach  #FatAdapted #Carnivore #sugarfree Disclaimer: The content on this channel is not medical advice. Please consult your healthcare provider.

If you feel totally confused by a negative Candida test from a stool sample, even though you've got candida overgrowth symptoms like thrush, dandruff, or stubborn skin issues, you're not alone. This is a very common problem – conflicting test results and symptoms – so what should you make of this?In this episode, you'll learn why false negatives on a Candida test are surprisingly common and the three specific problems with stool tests that create this confusion. So if you've been told you don't have candida overgrowth but your symptoms suggest otherwise, this conversation will offer insights so you can get better answers!⭐️Mentioned in This Episode:- See all the references

Women with psoriasis consistently show lower progesterone and DHEA, two hormones that normally quiet inflammation, making flare-ups stronger and more frequent Estrogen dominance — where estrogen feels too strong relative to progesterone — heightens immune reactivity and explains why symptoms worsen before your period, after childbirth and during menopause Intracellular estrogen, not blood estrogen, drives inflammation in psoriatic skin, which is why your labs can look "normal" even when your symptoms intensify Long-term hormone replacement therapy increases psoriasis risk by overstimulating inflammatory pathways, especially in post-menopausal women whose hormones are already shifting You can ease flare patterns by supporting progesterone and DHEA, eliminating estrogen-mimicking triggers, avoiding seed oils, optimizing vitamin D and reducing stress-related hormonal strain